320 related articles for article (PubMed ID: 30165291)
1. Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage.
Jakimovski D; Weinstock-Guttman B; Hagemeier J; Vaughn CB; Kavak KS; Gandhi S; Bennett SE; Fuchs TA; Bergsland N; Dwyer MG; Benedict RHB; Zivadinov R
J Neurol Sci; 2018 Oct; 393():128-134. PubMed ID: 30165291
[TBL] [Abstract][Full Text] [Related]
2. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
[TBL] [Abstract][Full Text] [Related]
3. Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort.
de Ruiter LRJ; Loonstra FC; Jelgerhuis JR; Coerver EME; Toorop AA; van Leeuwen ICE; Noteboom S; Moraal B; Strijbis EMM; Schoonheim MM; Uitdehaag BMJ
Mult Scler Relat Disord; 2023 Mar; 71():104568. PubMed ID: 36805177
[TBL] [Abstract][Full Text] [Related]
4. Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
Ruggieri S; Petracca M; Miller A; Krieger S; Ghassemi R; Bencosme Y; Riley C; Howard J; Lublin F; Inglese M
JAMA Neurol; 2015 Dec; 72(12):1466-74. PubMed ID: 26457955
[TBL] [Abstract][Full Text] [Related]
5. Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis.
Hubbard EA; Wetter NC; Sutton BP; Pilutti LA; Motl RW
J Neurol Sci; 2016 Apr; 363():225-31. PubMed ID: 27000254
[TBL] [Abstract][Full Text] [Related]
6. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
[TBL] [Abstract][Full Text] [Related]
7. Pallidal and caudate volumes correlate with walking function in multiple sclerosis.
Motl RW; Hubbard EA; Sreekumar N; Wetter NC; Sutton BP; Pilutti LA; Sosnoff JJ; Benedict RH
J Neurol Sci; 2015 Jul; 354(1-2):33-6. PubMed ID: 25959979
[TBL] [Abstract][Full Text] [Related]
8. Fully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MS.
Wetter NC; Hubbard EA; Motl RW; Sutton BP
Brain Behav; 2016 Mar; 6(3):e00440. PubMed ID: 26855828
[TBL] [Abstract][Full Text] [Related]
9. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
10. Cortical surface thickness, subcortical volumes and disability between races in relapsing-remitting multiple sclerosis.
Bross M; Hackett M; Bernitsas MM; Bao F; Carla-Santiago-Martinez ; Bernitsas E
Mult Scler Relat Disord; 2021 Aug; 53():103025. PubMed ID: 34052742
[TBL] [Abstract][Full Text] [Related]
11. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
Zivadinov R; Bergsland N; Hagemeier J; Carl E; Kolb H; Hojnacki D; Weinstock-Guttman B
J Neurol Sci; 2018 May; 388():175-181. PubMed ID: 29627017
[TBL] [Abstract][Full Text] [Related]
12. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
[TBL] [Abstract][Full Text] [Related]
13. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
[TBL] [Abstract][Full Text] [Related]
14. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.
Preziosa P; Pagani E; Morelli ME; Copetti M; Martinelli V; Pirro F; Falini A; Comi G; Filippi M; Rocca MA
Mult Scler; 2017 Dec; 23(14):1918-1928. PubMed ID: 28098510
[TBL] [Abstract][Full Text] [Related]
15. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
Nourbakhsh B; Azevedo C; Maghzi AH; Spain R; Pelletier D; Waubant E
J Neurol Sci; 2016 Jul; 366():229-233. PubMed ID: 27288812
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
Khalid F; Tauhid S; Chua AS; Healy BC; Stankiewicz JM; Weiner HL; Bakshi R
Int J Neurosci; 2017 May; 127(5):396-403. PubMed ID: 27143245
[TBL] [Abstract][Full Text] [Related]
17. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
[TBL] [Abstract][Full Text] [Related]
18. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
Chu R; Hurwitz S; Tauhid S; Bakshi R
BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
[TBL] [Abstract][Full Text] [Related]
19. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis.
Tjoa CW; Benedict RH; Weinstock-Guttman B; Fabiano AJ; Bakshi R
J Neurol Sci; 2005 Jul; 234(1-2):17-24. PubMed ID: 15993137
[TBL] [Abstract][Full Text] [Related]
20. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
